Wall Street Experts
ver. ZuMIgo(08/25)
West Pharmaceutical Services, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 2 876
EBIT TTM (mln): 593
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
469 |
430 |
397 |
420 |
491 |
542 |
700 |
913 |
1,020 |
1,051 |
1,056 |
1,105 |
1,192 |
1,266 |
1,368 |
1,421 |
1,400 |
1,509 |
1,599 |
1,717 |
1,840 |
2,147 |
2,832 |
2,887 |
2,950 |
2,893 |
Przychód Δ r/r |
0.0% |
-8.3% |
-7.7% |
5.7% |
16.9% |
10.4% |
29.2% |
30.5% |
11.7% |
3.0% |
0.4% |
4.6% |
7.9% |
6.2% |
8.1% |
3.9% |
-1.5% |
7.8% |
6.0% |
7.4% |
7.1% |
16.7% |
31.9% |
2.0% |
2.2% |
-1.9% |
Marża brutto |
38.4% |
32.6% |
29.3% |
28.0% |
31.8% |
28.8% |
27.5% |
28.7% |
28.6% |
28.8% |
28.8% |
28.8% |
28.5% |
30.6% |
31.8% |
31.5% |
32.6% |
33.2% |
32.1% |
31.8% |
32.9% |
35.8% |
41.5% |
39.4% |
38.3% |
34.5% |
EBIT (mln) |
66 |
36 |
41 |
27 |
54 |
48 |
72 |
101 |
95 |
124 |
98 |
91 |
110 |
135 |
162 |
182 |
129 |
197 |
229 |
240 |
297 |
407 |
752 |
734 |
676 |
570 |
EBIT Δ r/r |
0.0% |
-46.2% |
15.7% |
-35.4% |
104.1% |
-11.6% |
49.8% |
39.9% |
-6.0% |
30.8% |
-21.4% |
-7.0% |
20.8% |
23.3% |
20.2% |
12.1% |
-29.3% |
53.0% |
16.3% |
5.0% |
23.4% |
37.2% |
84.9% |
-2.4% |
-7.9% |
-15.7% |
EBIT (%) |
14.2% |
8.3% |
10.4% |
6.4% |
11.1% |
8.9% |
10.3% |
11.1% |
9.3% |
11.8% |
9.2% |
8.2% |
9.2% |
10.7% |
11.9% |
12.8% |
9.2% |
13.0% |
14.3% |
14.0% |
16.1% |
19.0% |
26.6% |
25.4% |
22.9% |
19.7% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16 |
14 |
17 |
18 |
15 |
15 |
13 |
12 |
7 |
6 |
6 |
5 |
7 |
7 |
8 |
9 |
3 |
EBITDA (mln) |
101 |
92 |
78 |
78 |
85 |
85 |
136 |
164 |
208 |
112 |
105 |
119 |
126 |
142 |
162 |
182 |
129 |
197 |
229 |
247 |
400 |
517 |
878 |
855 |
876 |
744 |
EBITDA(%) |
21.5% |
21.4% |
19.6% |
18.6% |
17.3% |
15.7% |
19.4% |
18.0% |
20.4% |
10.6% |
9.9% |
10.8% |
10.5% |
11.2% |
11.9% |
12.8% |
9.2% |
13.0% |
14.3% |
14.4% |
21.7% |
24.1% |
31.0% |
29.6% |
29.7% |
25.7% |
Podatek (mln) |
18 |
2 |
9 |
4 |
17 |
11 |
-0 |
25 |
17 |
24 |
14 |
14 |
24 |
33 |
40 |
47 |
26 |
54 |
81 |
41 |
59 |
72 |
107 |
115 |
122 |
108 |
Zysk Netto (mln) |
39 |
2 |
-5 |
18 |
32 |
19 |
46 |
67 |
71 |
86 |
73 |
65 |
76 |
81 |
112 |
127 |
96 |
144 |
151 |
207 |
242 |
346 |
662 |
586 |
593 |
493 |
Zysk netto Δ r/r |
0.0% |
-95.9% |
-425.0% |
-453.8% |
73.4% |
-39.2% |
135.1% |
47.1% |
5.4% |
21.6% |
-15.6% |
-10.1% |
15.6% |
6.9% |
39.2% |
13.2% |
-24.8% |
50.2% |
4.9% |
37.3% |
16.8% |
43.2% |
91.2% |
-11.5% |
1.3% |
-17.0% |
Zysk netto (%) |
8.2% |
0.4% |
-1.3% |
4.4% |
6.5% |
3.6% |
6.5% |
7.3% |
6.9% |
8.2% |
6.9% |
5.9% |
6.3% |
6.4% |
8.2% |
8.9% |
6.8% |
9.5% |
9.4% |
12.0% |
13.1% |
16.1% |
23.4% |
20.3% |
20.1% |
17.0% |
EPS |
0.65 |
0.025 |
-0.0907 |
0.33 |
0.75 |
0.57 |
0.75 |
1.05 |
1.08 |
1.33 |
1.11 |
0.98 |
1.12 |
1.19 |
1.61 |
1.79 |
1.33 |
1.96 |
2.04 |
2.8 |
3.27 |
4.68 |
8.9 |
7.88 |
7.99 |
6.75 |
EPS (rozwodnione) |
0.64 |
0.025 |
-0.0906 |
0.33 |
0.75 |
0.56 |
0.71 |
1.0 |
1.02 |
1.25 |
1.06 |
0.95 |
1.08 |
1.15 |
1.57 |
1.75 |
1.3 |
1.91 |
1.99 |
2.74 |
3.21 |
4.57 |
8.67 |
7.73 |
7.88 |
6.69 |
Ilośc akcji (mln) |
60 |
58 |
57 |
58 |
58 |
60 |
62 |
64 |
65 |
65 |
66 |
67 |
67 |
68 |
70 |
71 |
72 |
73 |
74 |
74 |
74 |
74 |
74 |
74 |
74 |
73 |
Ważona ilośc akcji (mln) |
60 |
58 |
57 |
58 |
58 |
62 |
65 |
67 |
72 |
72 |
73 |
73 |
74 |
72 |
71 |
73 |
74 |
75 |
76 |
75 |
75 |
76 |
76 |
76 |
75 |
74 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |